Compare Dominion Energy Inc (D) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

Dominion Energy (D) trades at $61.64, up 0.18% with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with 2025 revenue of $16.51B and net income of $3.00B, representing an 18.16% profit margin. Analyst consensus is mixed with 36% buy ratings but a $71.56 price target suggesting 16% upside. Key developments include the pending $67B merger with NextEra Energy and a $0.67 dividend payment scheduled for September 2026.

The stock presents a value opportunity with reasonable valuation metrics (P/E 21.37, P/S 2.96) and consistent profitability, though technical indicators signal near-term caution. The NextEra merger represents significant upside potential but carries regulatory approval risks. Current levels offer attractive entry for long-term investors seeking utility exposure with dividend income.

Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.

DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.